[DPRX] Dipexium Pharmaceuticals, Inc.
Overview
Type of security: Stock
Sector: Health Care
Industry: Major Pharmaceuticals
Market Capitalization:
Exchange: NASDAQ
The data is delayed by 15 minutes.
Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max
Chart type: absolute | relative to S&P
Description: Dipexium Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of antibiotics for the treatment of infectious diseases. It develops Locilex (pexiganan cream 0.8%), a novel, broad spectrum, and topical antibiotic, which is in phase 3 clinical trials for the treatment of mild infections of diabetic foot ulcers. The company was founded in 2010 and is based in New York, New York.
See how to gain 20% in 14 sec with TrendsInvesting
Fundamental Ratios
| Shares Outstanding | EPS | EPS Growth - 4 Quarters | EPS Growth - Q/Q | ||||
| EPS Growth - Y/Y | Sales Growth - 4 Quarters | Sales Growth - Q/Q | P/E | ||||
| P/E To EPS Growth | P/S | P/BV | Price/Cash Per Share | ||||
| Price/Free Cash Flow | ROA | -62.96% | ROE | -64.83% | ROI | ||
| Current Ratio | 34.57 | Quick Ratio | Long Term Debt/Equity | Debt Ratio | 0.03 | ||
| Gross Margin | Operating Margin | Net Profit Margin | Dividend Payout Ratio | ||||
| Dividend Yield |
Fundamental Data
| Cash From Financing Activities | Cash From Investing Activities | Cash From Operating Activities | -3.04 M | Gross Profit | |||
| Net Profit | -4.19 M | Operating Profit | -4.19 M | Total Assets | 24.18 M | Total Current Assets | 24.13 M |
| Total Current Liabilities | 700 K | Total Debt | Total Liabilities | 700 K | Total Revenue |
Technical Data
| High 52 week | 16.5 | Low 52 week | 1.1 | Last close | 1.34 | Last change | 0% |
| RSI | 40.83 | Average true range | 0.15 | Beta | 0.28 | Volume | 6.94 M |
| Simple moving average 20 days | 1.16% | Simple moving average 50 days | 3.55% | Simple moving average 200 days | -75.65% |
Performance Data
| Performance Week | 0% | Performance Month | 2.92% | Performance Quart | -10.8% | Performance Half | -43.06% |
| Performance Year | -89.25% | Performance Year-to-date | -16.38% | Volatility daily | 4.26% | Volatility weekly | 9.54% |
| Volatility monthly | 19.54% | Volatility yearly | 67.7% | Relative Volume | 3996.42% | Average Volume | 94.65 K |
| New High | New Low |
News
2017-04-24 09:20:13 | Houston real estate, energy, pharma cos. close more than $2B in deals
2017-04-18 05:00:44 | Dipexium Pharmaceuticals posts 1Q loss
2017-02-14 07:30:00 | PLx Pharma Announces Publication of Positive Antiplatelet Data for Aspertec in Peer-Reviewed Medical Journal JACC
2017-01-26 13:04:06 | DIPEXIUM PHARMACEUTICALS, INC. Financials
2017-01-25 17:36:00 | SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Dipexium Pharma - DPRX
2017-01-20 16:13:20 | DIPEXIUM PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report
2016-12-22 17:56:39 | Dipexium shares surge on announced merger with PLx Pharma
2016-12-22 16:51:26 | DIPEXIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Changes in Control or
2016-12-22 16:48:14 | Dipexium and PLx Pharma Announce Merger Agreement
2016-12-22 16:40:00 | 4:40 pm Dipexium Pharmaceuticals announces merger with PLx Pharma shares halted
2016-12-22 16:39:00 | Dipexium and PLx Pharma Announce Merger Agreement
2016-12-14 16:06:47 | DIPEXIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements an
2016-12-14 01:34:51 | Is Dipexium Pharmaceuticals Inc DPRX A Good Stock To Buy?
2016-11-16 16:06:40 | DIPEXIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
2016-11-10 07:11:23 | Dipexium Pharmaceuticals posts 3Q loss
2016-11-10 07:11:07 | Dipexium Pharmaceuticals Reports Third Quarter 2016 Financial Results
2016-11-10 07:00:00 | Dipexium Pharmaceuticals Reports Third Quarter 2016 Financial Results
2016-11-09 16:09:29 | DIPEXIUM PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
2016-10-31 16:08:02 | DIPEXIUM PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
2016-10-29 09:45:55 | 6 Companies That Destroyed Shareholders Last Week
2016-10-26 08:15:00 | Blog Coverage Dipexium Stock Tanks on Trial Failure
2016-10-25 16:09:00 | Is This the Beginning of the End of a Dipexium Implosion?
2016-10-25 16:07:00 | Dipexium Foot Ulcer Study Fails Big Time DPRX
2016-10-25 16:04:01 | Ericsson, Nike Drop in on Tuesday’s 52-Week Low Club
2016-10-25 12:32:35 | Blackberry BBRY’s Swan Song, Bear Attacks and Failed Drugs: 5 Stocks Getting Mauled by the Market Today
2016-10-25 11:35:56 | Dipexium Pharmaceuticals downgraded by Feltl & Co.
2016-10-25 08:22:22 | Dipexium's stock plunges in active trade after trial fails trials
2016-10-20 07:08:09 | Dipexium Provides Update on Availability of Results from Pivotal Phase 3 Clinical Trials with Locilex®
2016-10-20 07:00:00 | Dipexium Provides Update on Availability of Results from Pivotal Phase 3 Clinical Trials with Locilex®
2016-10-04 08:48:02 | Dipexium Receives European Medicines Agency Designation as a Small and Medium Enterprise
2016-10-04 08:00:00 | Dipexium Receives European Medicines Agency Designation as a Small and Medium Enterprise
2016-09-28 08:45:12 | Dipexium Pharmaceuticals DPRX Worth a Look: Stock Up 8.8%
2016-09-16 12:41:03 | Dipexium Pharmaceuticals, Inc. :DPRX-US: Earnings Analysis: Q2, 2016 By the Numbers : September 16, 2016
2016-09-07 08:09:10 | Dipexium Pharmaceuticals Announces Issuance of Locilex® Patent by European Union
2016-09-07 08:00:00 | Dipexium Pharmaceuticals Announces Issuance of Locilex® Patent by European Union
2016-09-01 08:45:12 | Dipexium Pharmaceuticals DPRX in Focus: Stock Gains 8.5%
2016-08-24 08:18:10 | Dipexium Pharmaceuticals Announces Participation in September Investor Conferences
2016-08-24 08:00:00 | Dipexium Pharmaceuticals Announces Participation in September Investor Conferences
2016-08-11 13:04:30 | DIPEXIUM PHARMACEUTICALS, INC. Financials
2016-08-04 07:22:16 | Dipexium Pharmaceuticals Reports Second Quarter 2016 Financial Results
2016-08-04 07:03:29 | Dipexium Pharmaceuticals posts 2Q loss
2016-08-04 07:00:00 | Dipexium Pharmaceuticals Reports Second Quarter 2016 Financial Results
2016-07-28 07:18:06 | Dipexium Pharmaceuticals to Hold Second Quarter 2016 Financial Results Conference Call on Thursday, August 4, 2016, at 8:30 a.m. ET
2016-07-28 07:00:00 | Dipexium Pharmaceuticals to Hold Second Quarter 2016 Financial Results Conference Call on Thursday, August 4, 2016, at 8:30 a.m. ET
2016-06-20 16:09:05 | Dipexium Pharmaceuticals' Locilex® Microbiology Data Presented at ASM Microbe 2016 Conference
2016-06-20 16:01:00 | Dipexium Pharmaceuticals' Locilex® Microbiology Data Presented at ASM Microbe 2016 Conference
2016-06-06 14:33:13 | Dipexium Pharmaceuticals, Inc. :DPRX-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016
2016-05-16 08:32:08 | Dipexium Announces Completion of Enrollment Objective in OneStep-1 Pivotal Phase 3 Clinical Trial